Skip to main content
CGEM logo

Cullinan Therapeutics, Inc.

CGEMNASDAQHealthcareBiotechnology

$12.91Today:- (-)1Y +78.23%

As of Oct 16, 2026 close

Market cap
$860.90M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$6.73$23.19
Volume (live)
-
Avg. volume (3M)
1.19M

Cullinan Therapeutics, Inc. (CGEM) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Cullinan Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy
Based on 12 unique analysts
(19 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$35.70
+176.53% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CGEM Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Robert Driscoll
Wedbush
BuyMaintains
$42.00
Samantha Semenkow
Citi
BuyMaintains
$33.00
Robert Burns
HC Wainwright
BuyReiterates
$35.00
Matt Phipps
William Blair
BuyReiterates
-
Julian Harrison
BTIG
BuyMaintains
$40.00
Julian Harrison
BTIG
BuyMaintains
$40.00
Robert Driscoll
Wedbush
BuyReiterates
$42.00
Samantha Semenkow
Citi
BuyMaintains
$33.00
Phil Nadeau
TD Cowen
BuyMaintains
-
Samantha Semenkow
Citi
BuyMaintains
$33.00
Unknown Analyst
Leerink Partners
BuyMaintains
$38.00 → $39.00
Sean Laaman
Morgan Stanley
BuyMaintains
$30.00
Boris Peaker
JonesTrading
BuyMaintains
$36.00
David Dai
UBS
BuyMaintains
$24.00 → $27.00
Kaveri Pohlman
Clear Street
BuyInitiates Coverage
$46.00 → $47.00
Alex Thompson CFA
Stifel Nicolaus
BuyMaintains
$28.00
Samantha Semenkow
Citi
BuyMaintains
$33.00
Robert Driscoll
Wedbush
BuyReiterates
$37.00
Julian Harrison
BTIG
BuyInitiates Coverage
$38.00 → $39.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 7, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CGEM?

The analyst consensus rating for CGEM is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for CGEM?

The average 12-month price target for CGEM is $35.70, representing an upside of 176.5% from the Oct 16, 2026 close of $12.91.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.